CTAG1A，作為癌癥/睪丸抗原家族的一員，其結(jié)構(gòu)獨(dú)特，編碼的蛋白質(zhì)具有特定的氨基酸序列和三維結(jié)構(gòu)，使其能夠與其他分子相互作用。功能上，CTAG1A主要在癌癥細(xì)胞中異常表達(dá)，成為潛在的免疫治療靶點(diǎn)，并可能參與細(xì)胞周期的調(diào)控。關(guān)于信號(hào)通路，盡管具體機(jī)制尚不完全明確，但CTAG1A很可能通過(guò)觸發(fā)免疫相關(guān)信號(hào)級(jí)聯(lián)反應(yīng)，如與免疫受體相互作用，進(jìn)而激活下游信號(hào)分子，如NF-κB或MAP激酶，從而引發(fā)免疫細(xì)胞的激活和細(xì)胞因子的產(chǎn)生，最終實(shí)現(xiàn)對(duì)表達(dá)CTAG1A的癌癥細(xì)胞的免疫應(yīng)答。因此，CTAG1A在癌癥免疫治療和細(xì)胞周期調(diào)控中扮演著重要角色，其具體的信號(hào)通路和作用機(jī)制仍需要進(jìn)一步的研究來(lái)揭示。

熱銷產(chǎn)品

Recombinant Human Cancer/testis antigen 1 (CTAG1A)

驗(yàn)證數(shù)據(jù)

SDS

(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.

LCMS

Based on the SEQUEST from database of E.coli host and target protein, the LC-MS/MS Analysis result of CSB-EP006125HU could indicate that this peptide derived from E.coli-expressed Homo sapiens (Human) CTAG1A.

LCMS

Based on the SEQUEST from database of E.coli host and target protein, the LC-MS/MS Analysis result of CSB-EP006125HU could indicate that this peptide derived from E.coli-expressed Homo sapiens (Human) CTAG1A.